| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |